Brief: Cizzle Biotechnology Says BIO To Launch CIZ1B Biomarker Test In USA
Aug 18 (Reuters) - Cizzle Biotechnology Holdings PLC CIZ.L: CIZZLE BIO INC TO LAUNCH CIZ1B BIOMARKER TEST IN USA CO & CIZZLE BIO REVISE PAYMENT SCHEDULE, ROYALTIES TO BE PAID BY 2026 END Source text: ID:nRSR6822Va Further company coverage: CIZ.L ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cizzle Biotechnology Holdings
See all newsRCS - Cizzle Biotechnology - Cizzle Shortlisted for One Nucleus Award 2026
Brief: Cizzle Biotechnology and Cizzle Bio Achieve CLIA Validation
Cizzle Biotechnology - Update on Launch of Lung Cancer Test in USA
Cizzle Biotechnology - Interim Results
Cizzle Biotechnology - Laboratory Expansion to Accelerate Sales in USA